Why Did iBio Shares Surge Over 11% In Pre-Market Trading? iBio Inc. (NASDAQ:IBIO) is trading up 11.51% to $1.55 in Thursday’s pre-market session. Benzinga · Oct 23, 2025
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Benzinga · Oct 21, 2025
It takes a village to get more students interested in science, technology Falling behind in education jeopardizes the future competitiveness of the region and country, especially in STEM fields where the U.S. already lags some other nations. Chicago Sun-Times · Dec 2, 2022
3 Biotech Penny Stocks to Avoid The biotech industry thrived during the pandemic. However, that seems to be fading as the pandemic situation has relaxed. And given the inherent volatility of penny stocks, iBio (IBIO), VistaGen Therapeutics (VTGN), and Timber Pharmaceuticals (TMBR) might be best avoided amid the broader market turmoil. Read more…. StockNews.com · Aug 23, 2022
iBio: Q3 Earnings Insights iBio (AMEX:IBIO) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings iBio missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05. Benzinga · May 12, 2022
Earnings Outlook For iBio iBio (AMEX:IBIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that iBio will report an earnings per share (EPS) of $-0.05. Benzinga · May 11, 2022
iBio Advances Its Vaccine Program for Multi-Variant COVID-19 Disease iBio Inc (NYSE: IBIO) Benzinga · Jan 26, 2022